Quarterly Results

202606 Results Summary

Revenue

The revenue stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Operating Profit

Operating Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

PBDT

PBDT stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Profit Before Tax

Profit Before Tax stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Net Profit

Net Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This represents a per cent year-on-year *(YoY) decline for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Company News

More

Earnings

CategoryQ4 FY25-26Q4 FY24-25Change %FY25-26FY24-25Change %
Total Revenue6,541.206,729.69-2.8028,162.5927,547.622.23
Expenses5,586.255,192.107.5922,555.6020,419.7210.46
Other Income148.16289.46-48.82882.01861.872.34
Operating Profit954.951,537.59-37.896,489.007,989.77-18.78
Depreciation382.92308.7324.031,210.981,106.959.40
Interest13.1314.02-6.3554.3962.01-12.29
Profit Before Tax699.461,493.42-53.165,223.636,820.81-23.42
Tax156.95279.28-43.801,440.951,708.35-15.65
Net Profit542.511,214.14-55.323,869.795,291.05-26.86
CategoryQ4 FY25-26Q3 FY25-26Change %
Total Revenue6,541.207,074.48-7.54
Expenses5,586.256,095.33-8.35
Other Income148.16206.34-28.20
Operating Profit954.95979.15-2.47
Depreciation382.92278.3537.57
Interest13.1314.03-6.41
Profit Before Tax699.46892.80-21.66
Tax156.95218.55-28.19
Net Profit542.51674.25-19.54

Research Reports

ActionTarget Price (₹)BrokerDateReports
Data Not Found

Financial Reports

Data not available.

Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Data Not Found

Corporate Information

Company News

Stocks to Watch today: Airtel, Tata Power, Cipla, RVNL, Dixon Tech and more

Stocks to watch today: Jewellery stocks, Tata Power, RVNL, Airtel, Cipla, Dixon Technologies, Dr Reddy's, Berger Paints are among others that will remain in focus today.

Updated On: 13 May 2026 | 8:06 AM IST

Cipla Q4 preview: Profit may plunge on weak US sales; check estimates here

Cipla's March 2026 quarter revenue is expected to decline marginally to ₹6,665 crore as compared to ₹6,730 crore in the year-ago period

Updated On: 12 May 2026 | 2:08 PM IST

Nifty Pharma hits 52-wk high; Wockhardt up 15%, Laurus, Lupin at new peaks

The Nifty Pharma index was quoting higher for the fifth straight trading day, surging 3.8 per cent during the period, as against 0.37 per cent gain in Nifty 50.

Updated On: 06 May 2026 | 1:15 PM IST

Nifty Pharma index soars 3%; Dr Reddy's, Piramal Pharma rally up to 9%

Glenmark Pharma, Cipla, Wockhardt, Mankind Pharma, Lupin, Zydus Life, Laurus, Ipca Labs, Divis Labs, Strides Pharma and Onesource were up in the range of 3% to 6%.

Updated On: 23 Apr 2026 | 11:33 AM IST

Pharma cos brace for soft Q4; US drag persists; domestic growth cushions

Pharma sector may see a 7 per cent Y-o-Y growth in reported sales and a 1 per cent increase in Ebitda, led by steady ex-gRevlimid US sales, healthy domestic growth, and favourable forex movements

Updated On: 15 Apr 2026 | 7:57 AM IST

Patent wins vs tariff risks: Analysts pick top pharma stocks to bet on

Pharma stocks have, so far, outperformed the markets in 2026. However, as risk around Trump tariffs resurface, analysts suggest shifting to domestic-focused companies. Here's the investment strategy.

Updated On: 06 Apr 2026 | 7:00 AM IST

Nifty Healthcare below 100-WMA, down 8% from its peak; what charts say?

Amol Athawale of Kotak Securities believes that the short-term outlook for Nifty Healthcare remains uncertain and sentiment may turn negative in case the index falls below 13,500 levels.

Updated On: 06 Apr 2026 | 11:19 AM IST

Trading guide: Nifty eyes 23,200; BSE, Laurus Labs, Cipla on analyst radar

Stocks to buy: Ajit Mishra of Religare Broking recommends buying BSE and Laurus Labs; also suggests Nifty trading strategy

Updated On: 02 Apr 2026 | 6:37 AM IST

Cipla tanks 20% so far in CY 2026; hits over 2-year low in firm market

Cipla declined 2% to ₹1,195.15, also its lowest level since December 2023 on the BSE in Wednesday's intra-day trade.

Updated On: 01 Apr 2026 | 2:58 PM IST

Focus on "stock-specific" opportunities: Analyst; suggests 2 stocks to buy

Ajit Mishra of Religare Broking recommends buying Cummins India, Granules and selling Cipla futures; check all details here

Updated On: 19 Mar 2026 | 7:37 AM IST
More